| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 3834 | 20515045 | IVRRADRAAVP | ES-2 | 11 | 60% inhibition at 2.5µg/ml |
| 3835 | 20515045 | IVRRADRAAVP | ES-2 | 11 | 60% inhibition at 5µg/ml |
| 3836 | 20515045 | IVRRADRAAVP | ES-2 | 11 | 60% inhibition at 10µg/ml |
| 3837 | 20515045 | ACDCRGDCFCGGGGIVRRADRAAVP | AP | 25 | 50% inhibition at 2.5µg/ml |
| 3838 | 20515045 | ACDCRGDCFCGGGGIVRRADRAAVP | AP | 25 | 40% inhibition at 5µg/ml |
| 3839 | 20515045 | ACDCRGDCFCGGGGIVRRADRAAVP | AP | 25 | 75% inhibition at 10µg/ml |
| 3840 | 20515045 | ACDCRGDCFCGGGGIVRRADRAAVP | AP(O) | 25 | 40% inhibition at 2.5µg/ml |
| 3841 | 20515045 | ACDCRGDCFCGGGGIVRRADRAAVP | AP(O) | 25 | 42% inhibition at 5µg/ml |
| 3842 | 20515045 | ACDCRGDCFCGGGGIVRRADRAAVP | AP(O) | 25 | 52% inhibition at 10µg/ml |
